DADA NEXUS LTD-ADR (DADA) Stock Fundamental Analysis

NASDAQ:DADA • US23344D1081

1.96 USD
-0.03 (-1.26%)
At close: Jun 16, 2025
1.93 USD
-0.03 (-1.53%)
After Hours: 6/16/2025, 8:00:01 PM
Overview Stock Chart Technical Analysis Fundamental Analysis Analyst Ratings Earnings Estimates Financials Ownership News
Fundamental Rating

4

Taking everything into account, DADA scores 4 out of 10 in our fundamental rating. DADA was compared to 38 industry peers in the Consumer Staples Distribution & Retail industry. While DADA has a great health rating, there are worries on its profitability. While showing a medium growth rate, DADA is valued expensive at the moment.


Dividend Valuation Growth Profitability Health

1

1. Profitability

1.1 Basic Checks

  • In the past year DADA has reported negative net income.
  • In the past year DADA has reported a negative cash flow from operations.
  • In the past 5 years DADA always reported negative net income.
  • DADA had a negative operating cash flow in each of the past 5 years.
DADA Yearly Net Income VS EBIT VS OCF VS FCFDADA Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2017 2018 2019 2020 2021 2022 2023 2024 -500M -1B -1.5B -2B -2.5B

1.2 Ratios

  • Looking at the Return On Assets, with a value of -39.11%, DADA is doing worse than 90.24% of the companies in the same industry.
  • Looking at the Return On Equity, with a value of -56.52%, DADA is doing worse than 80.49% of the companies in the same industry.
Industry RankSector Rank
ROA -39.11%
ROE -56.52%
ROIC N/A
ROA(3y)-29.05%
ROA(5y)-31.15%
ROE(3y)-40.15%
ROE(5y)-43.05%
ROIC(3y)N/A
ROIC(5y)N/A
DADA Yearly ROA, ROE, ROICDADA Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2017 2018 2019 2020 2021 2022 2023 2024 -20 -40 -60

1.3 Margins

  • DADA has a Gross Margin of 25.27%. This is in the better half of the industry: DADA outperforms 60.98% of its industry peers.
  • DADA's Gross Margin has improved in the last couple of years.
  • The Profit Margin and Operating Margin are not available for DADA so they could not be analyzed.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM 25.27%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y0.16%
GM growth 5Y25.28%
DADA Yearly Profit, Operating, Gross MarginsDADA Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2017 2018 2019 2020 2021 2022 2023 2024 0 -50 -100

More info and screens

ROAROEROICOperating and Profit MarginShow most profitable peers

7

2. Health

2.1 Basic Checks

  • DADA does not have a ROIC to compare to the WACC, probably because it is not profitable.
  • DADA has less shares outstanding than it did 1 year ago.
  • Compared to 5 years ago, DADA has more shares outstanding
  • DADA has no outstanding debt. Therefor its Debt/Equity and Debt/FCF ratios are 0 and belong to the best of the industry.
DADA Yearly Shares OutstandingDADA Yearly Shares OutstandingYearly Shares Outstanding 2017 2018 2019 2020 2021 2022 2023 2024 50M 100M 150M 200M 250M
DADA Yearly Total Debt VS Total AssetsDADA Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2017 2018 2019 2020 2021 2022 2023 2024 2B 4B 6B 8B

2.2 Solvency

  • Based on the Altman-Z score of -1.45, we must say that DADA is in the distress zone and has some risk of bankruptcy.
  • DADA has a Altman-Z score of -1.45. This is amonst the worse of the industry: DADA underperforms 92.68% of its industry peers.
  • DADA has no outstanding debt. Therefor its Debt/Equity and Debt/FCF ratios are 0 and belong to the best of the industry.
Industry RankSector Rank
Debt/Equity 0
Debt/FCF N/A
Altman-Z -1.45
ROIC/WACCN/A
WACC7.54%
DADA Yearly LT Debt VS Equity VS FCFDADA Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2017 2018 2019 2020 2021 2022 2023 2024 0 2B -2B 4B 6B

2.3 Liquidity

  • A Current Ratio of 3.27 indicates that DADA has no problem at all paying its short term obligations.
  • DADA has a better Current ratio (3.27) than 97.56% of its industry peers.
  • DADA has a Quick Ratio of 3.27. This indicates that DADA is financially healthy and has no problem in meeting its short term obligations.
  • Looking at the Quick ratio, with a value of 3.27, DADA belongs to the top of the industry, outperforming 97.56% of the companies in the same industry.
Industry RankSector Rank
Current Ratio 3.27
Quick Ratio 3.27
DADA Yearly Current Assets VS Current LiabilitesDADA Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2017 2018 2019 2020 2021 2022 2023 2024 2B 4B 6B

More info and screens

WACCDebt/EquityHow to determine the health of a companyAltman-Z scoreShow peers with great health

5

3. Growth

3.1 Past

  • The earnings per share for DADA have decreased strongly by -13.10% in the last year.
  • The Revenue has decreased by -5.74% in the past year.
  • DADA shows a strong growth in Revenue. Measured over the last years, the Revenue has been growing by 25.54% yearly.
EPS 1Y (TTM)-13.1%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%80%
Revenue 1Y (TTM)-5.74%
Revenue growth 3Y12.07%
Revenue growth 5Y25.54%
Sales Q2Q%-11.61%

3.2 Future

  • DADA is expected to show a strong growth in Earnings Per Share. In the coming years, the EPS will grow by 21.89% yearly.
  • The Revenue is expected to grow by 15.26% on average over the next years. This is quite good.
EPS Next Y-120.46%
EPS Next 2Y20.69%
EPS Next 3Y55.87%
EPS Next 5Y21.89%
Revenue Next Year12.27%
Revenue Next 2Y12.78%
Revenue Next 3Y15.13%
Revenue Next 5Y15.26%

3.3 Evolution

  • The estimated forward Revenue growth is still strong, although it is decreasing when compared to the stronger growth in the past years.
DADA Yearly Revenue VS EstimatesDADA Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 2031 2032 5B 10B 15B 20B 25B
DADA Yearly EPS VS EstimatesDADA Yearly EPS VS EstimatesYearly EPS VS Estimates 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 2031 0 -2 -4 -6 -8

More info and screens

Find the best growth stocksShow best growing peers

1

4. Valuation

4.1 Price/Earnings Ratio

  • DADA reported negative earnings for the last year, which makes the Price/Earnings Ratio negative.
  • Also next year DADA is expected to report negative earnings again, which makes the also the Forward Price/Earnings Ratio negative.
Industry RankSector Rank
PE N/A
Fwd PE N/A
DADA Price Earnings VS Forward Price EarningsDADA Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 10 -10 20

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A
DADA Per share dataDADA EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 1 2 3 4 5

4.3 Compensation for Growth

  • A more expensive valuation may be justified as DADA's earnings are expected to grow with 55.87% in the coming years.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y20.69%
EPS Next 3Y55.87%

More info and screens

Price/EarningsPrice/FCFFCF per shareEV/EBITDAPEG RATIOShow best valued peers

0

5. Dividend

5.1 Amount

  • No dividends for DADA!.
Industry RankSector Rank
Dividend Yield N/A

More info and screens

Find the best dividend stocksShow peers with best dividend

DADA NEXUS LTD-ADR

NASDAQ:DADA (6/16/2025, 8:00:01 PM)

After market: 1.93 -0.03 (-1.53%)

1.96

-0.03 (-1.26%)

Chartmill FA Rating
GICS SectorConsumer Staples
GICS IndustryGroupConsumer Staples Distribution & Retail
GICS IndustryConsumer Staples Distribution & Retail
Earnings (Last)05-13
Earnings (Next)08-18
Inst Owners20.11%
Inst Owner Change0%
Ins OwnersN/A
Ins Owner ChangeN/A
Market Cap506.16M
Revenue(TTM)9.66B
Net Income(TTM)-2.04B
Analysts78
Price Target1.76 (-10.2%)
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)2
Avg EPS beat(2)95.04%
Min EPS beat(2)92.42%
Max EPS beat(2)97.65%
EPS beat(4)3
Avg EPS beat(4)56.84%
Min EPS beat(4)-43.76%
Max EPS beat(4)97.65%
EPS beat(8)5
Avg EPS beat(8)33.85%
EPS beat(12)8
Avg EPS beat(12)23.76%
EPS beat(16)11
Avg EPS beat(16)19.11%
Revenue beat(2)1
Avg Revenue beat(2)0.03%
Min Revenue beat(2)-0.63%
Max Revenue beat(2)0.68%
Revenue beat(4)2
Avg Revenue beat(4)-1.46%
Min Revenue beat(4)-6.42%
Max Revenue beat(4)0.68%
Revenue beat(8)2
Avg Revenue beat(8)-3.02%
Revenue beat(12)2
Avg Revenue beat(12)-2.42%
Revenue beat(16)5
Avg Revenue beat(16)-1.02%
PT rev (1m)-6.76%
PT rev (3m)-58.15%
EPS NQ rev (1m)0%
EPS NQ rev (3m)25.28%
EPS NY rev (1m)0%
EPS NY rev (3m)-4.76%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)0%
Revenue NY rev (1m)0%
Revenue NY rev (3m)1.45%
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S 0.38
P/FCF N/A
P/OCF N/A
P/B 1.01
P/tB 1.01
EV/EBITDA N/A
EPS(TTM)-0.13
EYN/A
EPS(NY)-0.29
Fwd EYN/A
FCF(TTM)-0.57
FCFYN/A
OCF(TTM)-0.57
OCFYN/A
SpS5.22
BVpS1.95
TBVpS1.95
PEG (NY)N/A
PEG (5Y)N/A
Graham NumberN/A
Profitability
Industry RankSector Rank
ROA -39.11%
ROE -56.52%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM 25.27%
FCFM N/A
ROA(3y)-29.05%
ROA(5y)-31.15%
ROE(3y)-40.15%
ROE(5y)-43.05%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexgc growth 3YN/A
ROICexgc growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y0.16%
GM growth 5Y25.28%
F-Score5
Asset Turnover1.85
Health
Industry RankSector Rank
Debt/Equity 0
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr 1.23%
Cap/Sales 0.06%
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 3.27
Quick Ratio 3.27
Altman-Z -1.45
F-Score5
WACC7.54%
ROIC/WACCN/A
Cap/Depr(3y)1.13%
Cap/Depr(5y)4.8%
Cap/Sales(3y)0.06%
Cap/Sales(5y)0.17%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-13.1%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%80%
EPS Next Y-120.46%
EPS Next 2Y20.69%
EPS Next 3Y55.87%
EPS Next 5Y21.89%
Revenue 1Y (TTM)-5.74%
Revenue growth 3Y12.07%
Revenue growth 5Y25.54%
Sales Q2Q%-11.61%
Revenue Next Year12.27%
Revenue Next 2Y12.78%
Revenue Next 3Y15.13%
Revenue Next 5Y15.26%
EBIT growth 1Y4.36%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year49.17%
EBIT Next 3Y22.76%
EBIT Next 5Y19.94%
FCF growth 1Y-173.76%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y-177.39%
OCF growth 3YN/A
OCF growth 5YN/A

DADA NEXUS LTD-ADR / DADA FAQ

What is the fundamental rating for DADA stock?

ChartMill assigns a fundamental rating of 4 / 10 to DADA.


What is the valuation status for DADA stock?

ChartMill assigns a valuation rating of 1 / 10 to DADA NEXUS LTD-ADR (DADA). This can be considered as Overvalued.


What is the profitability of DADA stock?

DADA NEXUS LTD-ADR (DADA) has a profitability rating of 1 / 10.


What is the financial health of DADA NEXUS LTD-ADR (DADA) stock?

The financial health rating of DADA NEXUS LTD-ADR (DADA) is 7 / 10.